[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

When and How You Become Refractory to a Drug and How to Find the Best Next Treatment

When and How You Become Refractory to a Drug and How to Find the Best Next Treatment image

When and How You Become Refractory to a Drug and How to Find the Best Next Treatment

Webinar
event Feb 22, 2023 / 01:00PM - 02:00PM EST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Many patients wonder how one becomes refractory to a drug, and how the specialist knows what the next best step is to take. How long should you let your numbers increase without making a change in treatment? When is it ok to let it ride and for how long? And with all the different options, how can you truly know what your "next best option" really is? Learn the answers to these questions and more as we hear from myeloma specialist Dr. Omar Nadeem from Dana Farber Cancer Institute.

Schedule & Agenda

The panelist Audrey Burton-Bethke
01:00 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Dr. Omar Nadeem.

The panelist Omar Nadeem, MD
01:05 PM
Presentation
Omar Nadeem, MD

Dr. Omar Nadeem talks about how one becomes refractory to a drug, and how the specialist knows what the next best step is to take.

Event panelist Audience
01:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Omar Nadeem, MD
Omar Nadeem, MD

Dr. Nadeem completed his internal medicine residency training at Dartmouth-Hitchcock Medical Center and his hematology/oncology fellowship at the Warren Alpert Medical School of Brown University. He is board certified in internal medicine, hematology and medical oncology. He joined the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute in 2018. He is an Instructor in Medicine at Harvard Medical School and serves as the Clinical Director of Myeloma Cellular Therapies Program and Director of Myeloma and Plasma Cell Pathways at the Dana-Farber Cancer Institute. His clinical and research interests include studying the role of immunotherapy and cellular therapies in multiple myeloma, with particular focus on CAR T-cell therapy. He serves as a principal investigator of several clinical trials in smoldering multiple myeloma, newly diagnosed disease and relapsed and refractory multiple myeloma. He also attends in the Center of Prevention of Progression (CPOP) clinic at DFCI, which is focused on management of patients with precursor plasma cell disorders.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Disease Progression and Relapsed/Refractory group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.